Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0029463 (osteosarcoma)
 16,637 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Cancer chiefly occurs in vertebrates. Rare in amphibians, and perhaps common in reptiles, various neoplasms and malignant cancers have been reported with erratic frequency by museums, paleontologists, veterinarians, and pet hobbyists. Unsurprisingly, most herpetofaunal diversity has never been systematically surveyed for the presence of neoplasms owing to the extreme rarity or obscurity of many species. Museum collections can fill these gaps in knowledge, especially when researchers use non-destructive techniques. In this study, we used X-ray computed tomography (CT) to discover and characterize a possible osteosarcoma of the spine in a rare South American coralsnake, Micrurus ancoralis. Two spinal vertebrae were completely fused and adjacent vertebrae showed evidence of corruption. The fused vertebrae contained a hollow inner network thought to be vascular tissue. We also review previous reports of neoplasms in the Elapidae and all bony neoplasms in non-avian reptiles. The rarely reported technique of X-ray CT for tumor discovery could greatly improve our understanding of the species diversity and perhaps underlying causes of neoplasia.
 ...
PMID:Possible osteosarcoma reported from a new world elapid snake and review of reptilian bony tumors. 3286 68

IL-10 is a potent anti-inflammatory cytokine capable of suppressing a number of proinflammatory signals associated with intestinal inflammatory diseases, such as ulcerative colitis and Crohn's disease. Clinical use of human IL-10 (hIL-10) has been limited by anemia and thrombocytopenia following systemic injection, side effects that might be eliminated by a gut-restricted distribution. We have identified a transcytosis pathway used by cholix, an exotoxin secreted by nonpandemic forms of the intestinal pathogen Vibrio cholerae A nontoxic fragment of the first 386 aa of cholix was genetically fused to hIL-10 to produce recombinant AMT-101. In vitro and in vivo characterization of AMT-101 showed it to efficiently cross healthy human intestinal epithelium (SMI-100) by a vesicular transcytosis process, activate hIL-10 receptors in an engineered U2OS osteosarcoma cell line, and increase cellular phospho-STAT3 levels in J774.2 mouse macrophage cells. AMT-101 was taken up by inflamed intestinal mucosa and activated pSTAT3 in the lamina propria with limited systemic distribution. AMT-101 administered to healthy mice by oral gavage or to cynomolgus monkeys (nonhuman primates) by colonic spray increased circulating levels of IL-1R antagonist (IL-1Ra). Oral gavage of AMT-101 in two mouse models of induced colitis prevented associated pathological events and plasma cytokine changes. Overall, these studies suggest that AMT-101 can efficiently overcome the epithelial barrier to focus biologically active IL-10 to the intestinal lamina propria.
 ...
PMID:A Novel Fusion of IL-10 Engineered to Traffic across Intestinal Epithelium to Treat Colitis. 3314 17


<< Previous 1 2 3 4 5 6 7 8